World's Best Scientists 2026 revealed!
Marketa Zvelebil

Marketa Zvelebil

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
15276
World Ranking
9624
National Ranking
166

Overview

Marketa Zvelebil is affiliated with the University of Basel in Switzerland. Their academic profile includes research contributions in various scientific areas, although specific details on main fields of study, subfields, or topics are not provided.

There is no available information on recent papers, so details about titles, years of publication, and publication venues are not present.

The scientist does not have documented frequent co-authors or recurring publication venues reported in the available data.

No book publications or details regarding publishers associated with their work have been identified.

Information about awards or recognitions linked to Marketa Zvelebil is absent from the data.

This profile reflects the data currently accessible and does not include assessments or evaluations of their work.

Best Publications

  • The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†

    Adrian J. Folkes;Khatereh Ahmadi;Wendy K. Alderton;Sonia Alix

  • Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.

    M P Wymann;G Bulgarelli-Leva;M J Zvelebil;L Pirola

  • Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase.

    K Salim;M J Bottomley;E Querfurth;M J Zvelebil

  • Prediction of protein secondary structure and active sites using the alignment of homologous sequences.

    Markéta J. Zvelebil;Geoffrey J. Barton;William R. Taylor;Michael J.E. Sternberg

  • p110δ, a novel phosphoinositide 3-kinase in leukocytes

    Bart Vanhaesebroeck;Melanie J. Welham;Kei Kotani;Rob Stein

  • Phosphoinositide 3-kinase signalling – which way to target?

    Matthias P Wymann;Marketa Zvelebil;Muriel Laffargue

  • Exploring the specificity of the PI3K family inhibitor LY294002.

    Severine I. Gharbi;Marketa J. Zvelebil;Stephen J. Shuttleworth;Tim Hancox

  • Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit.

    Nabil Miled;Ying Yan;Wai Ching Hon;Olga Perisic

  • A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system.

    Stefano Volinia;Ritu Dhand;Bart Vanhaesebroeck;Lindsay K. MacDougall

  • Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system.

    Severine Gharbi;Piers Gaffney;Alice Yang;Marketa J. Zvelebil

  • Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

    Munir R. Tanas;Andrea Sboner;Andre M. Oliveira;Michele R. Erickson-Johnson

  • Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin.

    Jan Domin;Françoise Pages;Stefano Volinia;Susan E. Rittenhouse

  • iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

    Daniele Bergamaschi;Yardena Samuels;Yardena Samuels;Yardena Samuels;Alexandra Sullivan;Marketa Zvelebil

  • A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC

    Charis Eng;D. P. Smith;L. M. Mulligan;C. S. Healey

  • IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.

    Mads Gyrd-Hansen;Maurice Darding;Maria Miasari;Massimo M. Santoro;Massimo M. Santoro

  • Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases

    C. Hugh Reynolds;Claire J. Garwood;Selina Wray;Caroline Price

  • Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.

    Martin J. Page;Bob Amess;R. Reid Townsend;Raj Parekh

  • Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate

    Howard Kendrick;Joseph Regan;Fiona-Ann Magnay;Anita Grigoriadis

  • Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid‐binding C2 domain

    Ruth Uellner;Marketa J. Zvelebil;Jean Hopkins;Jane Jones

  • Class II Phosphoinositide 3-Kinases Are Downstream Targets of Activated Polypeptide Growth Factor Receptors

    Alexandre Arcaro;Marketa J. Zvelebil;Christian Wallasch;Axel Ullrich

Frequent Co-Authors

Michael D. Waterfield
Michael D. Waterfield Ludwig Cancer Research
Alan Ashworth
Alan Ashworth University of California, San Francisco
Christopher J. Lord
Christopher J. Lord Institute of Cancer Research
Alan Mackay
Alan Mackay Institute of Cancer Research
Rainer Cramer
Rainer Cramer University of Reading
Nick Orr
Nick Orr Queen's University Belfast
Clare M. Isacke
Clare M. Isacke Institute of Cancer Research
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
Matthias P. Wymann
Matthias P. Wymann University of Basel
Janet M. Thornton
Janet M. Thornton European Bioinformatics Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry often explore interdisciplinary fields such as health information management, medical coding, or billing. These roles blend scientific knowledge with data organization, critical for supporting modern healthcare systems.

One key pathway is pursuing a health information management degree. Many programs are available online, making this a flexible option. Graduates can oversee medical records, patient data, and healthcare informatics.

Another popular career involves medical coding and billing. If you're wondering how long does it take to become a medical coder, the answer is typically less than a year with certification programs. These professionals are crucial for accurate healthcare billing and data tracking.

Understanding the distinctions between certifications such as ccs vs cpc is important, as each opens different career routes and salary prospects within coding.

The job outlook for medical billing and coding remains strong, with ongoing demand for skilled professionals. These allied health roles offer stable employment and can complement a bioscience background.

Best Scientists Citing Marketa Zvelebil

Trending Scientists

Recently Published Articles